Nuclear Imaging Equipment Market, By Product Type (Single Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), Hybrid PET-CT, Hybrid SPECT-CT, Hybrid PET-MRI, and Others), By Application (Oncology, Cardiology, Neurology, and Others), By End User (Hospitals and clinics, Diagnostic imaging centers, Research institutes, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Published In : Jan 2024

Code : CMI2366

Pages :180

Formats :

Excel and PDF

Industry : Medical Devices

Nuclear Imaging Equipment MarketSize and Trends

Global nuclear imaging equipment market size is expected to reach US$ 4.29 Bn by 2030, from US$ 3.07 Bn in 2023, exhibiting a compound annual growth rate (CAGR) of 4.9% during the forecast period. Nuclear imaging devices are the devices which are commonly employed in radioactive materials to assess the severity of illnesses including cancer, endocrine, gastrointestinal, cardiovascular, neurological, and other brain disorders. By providing operational data at the molecular and cellular levels, these non-invasive devices help the clinicians to assess and diagnose medical issues. In the field of nuclear imaging, positron emission tomography (PET) systems, single photon emission computed tomography (SPECT) systems and planar scintigraphy are the main product categories.

Global Nuclear Imaging Equipment Market Trends:

Increasing adoption of PET: Rising adoption of positron emission tomography (PET) scanners for diagnostic imaging is having a major positive impact on the global nuclear imaging equipment market. PET provides superior functional imaging as compared to other modalities and allows clinicians to diagnose diseases early and accurately. It has replaced several invasive diagnostic procedures. According to the National Cancer Institute, over 750,000 PET scans are performed in the U.S. each year till 2021. Nuclear medicine procedures using PET have increased by over 50% in the past decade alone. According to the Hospital Authority in Hong Kong, the number of PET examinations conducted rose from around 16,000 in 2015 to over 30,000 in 2020. Similarly, the National Health Service England review noted that MRI and PET imaging increased substantially post-pandemic to clear backlogs. This increased clinical demand which is driving more expenditure on nuclear medicine technologies across both developed and emerging markets. Major original equipment manufacturers (OEMs) have reported strong order books for PET and hybrid PET systems over the last two years.